Exosomes Market - By Products & Services (Kits & Reagents, Instruments), Application (Diagnostic, Therapeutic), Indication (Cancer, Infectious Diseases), End-users (Pharmaceutical & Biotechnology Companies), Forecast, 2023-2032

List of Tables

Exosomes Market size is poised to expand at 29.9% CAGR from 2023-2032 driven by increasing adoption in regenerative medicine and cell-based therapies.

The growing focus on regenerative medicine, with particular emphasis on stem cell therapies is driving the demand for exosome-based treatments. On account of their ability to transport bioactive molecules, such as nucleic acids and proteins, exosomes have emerged as promising candidates for therapeutic interventions. Furthermore, several market players are collaborating with local medical research institutes to conduct innovative studies to focus on regenerative potential of exosomes, further augmenting the industry outlook. To cite an instance, in September 2023, dG Medical Group launched research on the use of mesenchymal stem cell exosomes to treat major medical disorders.

The exosomes industry is segmented into products & services, application, indication, end-user, and region.

Based on products & services, the market share from the instruments segments is anticipated to record 25.5% CAGR from 2023-2032. Specialized instruments designed for exosome isolation, characterization, and analysis are witnessing significant demand in advancing exosome research. High-performance ultracentrifugation systems, microfluidic devices, and innovative analytical platforms also enable precise handling and study of exosomes. Moreover, the rising technological advancements in exosome instrumentation are leading to improved scalability and reliability of processes for meeting the evolving needs of the research and clinical communities.

In terms of application, the exosomes industry size from the diagnostic segment is estimated to record 25.8% growth rate through 2032. Exosomes offer non-invasive means of detecting and monitoring diseases, such as cancer, neurodegenerative disorders, and infectious diseases. Additionally, the rising demand for early and accurate disease detection coupled with advancements in exosome isolation and analysis technologies will boost the segment expansion.

Regionally, the Asia Pacific exosomes market is projected to exhibit robust growth rate through 2032 owing to the increasing research activities and the expanding biotechnology and healthcare sectors across the region. The rising prevalence of chronic diseases and the growing interest in precision medicine are surging the demand for exosome-based diagnostics and therapeutics. Additionally, the growing collaborative efforts between research institutions and biotech companies in several Asian countries is fostering innovations in exosome applications, propelling the regional industry growth.

Product Code: 6862

Chapter 1 Methodology & Scope

1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Covid-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Global exosomes market 360 degree synopsis, 2018 - 2032 (USD Million)
- 2.1.1 Business trends
- 2.1.2 Region trends
- 2.1.3 Products & services trends
- 2.1.4 Application trends
- 2.1.5 Indication trends
- 2.1.6 End-users trends

Chapter 3 Exosomes Market Insights

3.1 Industry landscape
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing technological advancements in exosome isolation
  - 3.2.1.2 Rising government and non-government initiatives for exosome research
  - 3.2.1.3 Increasing prevalence of cancer
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Lack of standardization
  - 3.2.2.2 Ethical & privacy concerns
3.3 Growth potential analysis
- 3.3.1 By products & services
- 3.3.2 By application
- 3.3.3 By indication
- 3.3.4 By end-users
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic dashboard, 2022

Chapter 5 Exosomes Market Estimates and Forecast, By Products & Services, 2018 - 2032 (USD Million)

5.1 Key trends, by products & services
5.2 Kits & reagents
- 5.2.1 Antibodies
- 5.2.2 Isolation, purification, quantitation kits & reagents
- 5.2.3 Other kits & reagents
5.3 Instruments
5.4 Services

Chapter 6 Exosomes Market Estimates and Forecast, By Application, 2018 - 2032 (USD Million)

6.1 Key trends, by application
6.2 Diagnostic
6.3 Therapeutic

Chapter 7 Exosomes Market Estimates and Forecast, By Indication, 2018 - 2032 (USD Million)

7.1 Key trends, by indication
7.2 Cancer
7.3 Neurodegenerative diseases
7.4 Cardiovascular diseases
7.5 Infectious diseases
7.6 Other indications

Chapter 8 Exosomes market Estimates and Forecast, By End-users, 2018 - 2032 (USD Million)

8.1 Key trends, by end-users
8.2 Pharmaceutical & biotechnology companies
8.3 Hospitals & diagnostics centers
8.4 Academic & research institutes

Chapter 9 Exosomes Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

9.1 Key trends, by region
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
9.6 Middle East & Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

10.1 Thermo Fisher Scientific, Inc.
10.2 Bio-Techne Corp
10.3 QIAGEN
10.4 Beckam Coulter (Danaher Corp)
10.5 Diagenode (Hologic Inc)
10.6 Lonza
10.7 Abcam
10.8 RoosterBio, Inc.
10.9 Miltenyi Biotec
10.10 Fujifilm Holdings Corp.
10.11 Hitachi Chemical Diagnostics Inc.
10.12 Clara Biotech